Kiniksa Pharmaceuticals Ltd. (KNSA) to Offer $100M in Class A Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil hits one-week low as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Kiniksa Pharmaceuticals Ltd. (KNSA) Prices 5.95M Share Upsied Common Offering at $21/Sh
July 22, 2020 5:48 AM EDTKiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) announced today the pricing of its public offering of 5,952,381 Class A common shares at a public offering price of $21.00 per share, before underwriting discounts and commissions. The gross proceeds to Kiniksa from this offering, together with the proceeds of the... More
